Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Therapie|May 29, 2018
[ISO 9001certification of a quality management system in a clinical investigation center]Jimmy Chesnais, Claire Fougerou-Leurent, Claire Laforest, et al.British Journal of Clinical Pharmacology|September 1, 2019
Impact of a targeted monitoring on data-quality and data-management workload of randomized controlled trials: A prospective comparative studyClaire Fougerou-Leurent, Bruno Laviolle, Christelle Tual, et al.Journal of Neuroradiology = Journal De Neuroradiologie|December 16, 2021
Rehearsals using patient-specific 3D-printed aneurysm models for simulation of endovascular embolization of complex intracranial aneurysms: 3D SIM studyAnthony Le Bras, Fakhreddine Boustia, Kevin Janot, et al.International Journal of Molecular Sciences|February 5, 2021
Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum DisorderSébastien Lalanne, Claire Fougerou-Leurent, George M Anderson, et al.Fundamental & Clinical Pharmacology|April 18, 2026
Evaluating the Environmental Impact of Clinical Research: A Full Life Cycle Analysis of a French Academic Randomised Clinical TrialClaire Fougerou-Leurent, Louise Forteau, Maëlle Perrot-Loyer, et al.Therapie|May 16, 2020
[A survey on French hospital physicians'certification to the good clinical practices]Claire Fougerou-Leurent, Jimmy Chesnais, Sabrina Nekmouche, et al.Clinics and Research in Hepatology and Gastroenterology|September 19, 2022
HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantationAudrey Coilly, Mylène Sebagh, Claire Fougerou-Leurent, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2015
Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver TransplantationVincent Leroy, Jérôme Dumortier, Audrey Coilly, et al.Contemporary Clinical Trials|June 11, 2023
Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy studyClaire Fougerou-Leurent, Christelle Delmas, Juliette Saillard, et al.BMJ Open|October 29, 2025
Impact of intraoperatiVe moderAte positive end-expiratory pressure with reCruitment mAnoeuvres versus low positive end-expiRatory pressure on major postoperative pulMonary complications and death after on-pump cardiac surgery in high-risk patients: the VACARM randomised clinical trial-study protocolNathalie Demaure, Jehanne Le Cunff, Maryline Duchêne, et al.Pageof 3